DOI:
10.1055/s-00042410
Revista Brasileira de Ortopedia
LinksClose Window
References
Levitan B, Yuan Z, Turpie AG, Friedman RJ, Homering M, Berlin JA. , et al.
Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.
Vasc Health Risk Manag 2014;
10 (10) 157-67
Access:
We do not assume any responsibility for the contents of the web pages of other providers.